Opus Genetics, Inc. (IRD)
NASDAQ: IRD · Real-Time Price · USD
3.470
-0.350 (-9.16%)
At close: Oct 23, 2026, 4:00 PM EDT
3.610
+0.140 (4.03%)
Pre-market: Oct 26, 2026, 5:39 AM EDT
Opus Genetics Market Cap
Opus Genetics has a market cap or net worth of $288.69 million as of October 23, 2026. It is the 18,359th most valuable company in the world and the 3,232nd biggest in the United States. Its market cap has increased by 134.82% in one year.
Market Cap
288.69M
Enterprise Value
236.08M
1-Year Change
134.82%
Global Rank
Country Rank
#3,232 United States
Category
ChartMarket Cap Chart
Since November 6, 2020, Opus Genetics's market cap has increased from $21.26M to $288.69M, an increase of 1,257.74%. That is a compound annual growth rate of 54.86%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 288.69M | 108.26% |
| Dec 31, 2025 | 138.62M | 268.99% |
| Dec 31, 2024 | 37.57M | -44.87% |
| Dec 29, 2023 | 68.14M | -7.23% |
| Dec 30, 2022 | 73.45M | 13.82% |
| Dec 31, 2021 | 64.53M | -8.29% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 6, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Contineum Therapeutics | 312.63M |
| Turn Therapeutics | 306.22M |
| Benitec Biopharma | 301.74M |
| Artiva Biotherapeutics | 300.67M |
| Scribe Therapeutics | 291.64M |
| Inhibikase Therapeutics | 289.50M |
| Agenus | 284.98M |
| Fulcrum Therapeutics | 280.77M |